<DOC>
	<DOCNO>NCT00457899</DOCNO>
	<brief_summary>The purpose study determine whether increase amount ( dose ) quetiapine IR ( immediate release formulation ) rapidly conventional dose increase , improves control symptom measure Positive Negative Syndrome Scale ( PANSS ) - psychiatric assessment scale measure positive negative symptom - patient acute schizophrenia schizoaffective disorder .</brief_summary>
	<brief_title>Rapid Versus Conventional Titration Quetiapine Schizophrenia/Schizoaffective Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Men woman , age 18 65 year , require treatment acute episode schizophrenia/schizoaffective disorder judge doctor Significant unstable condition hear , circulation , blood , liver , kidney ; malignancy ( cancer ) ; diabetes ( mellitus ) ; history fit faint . Resistance antipsychotic medication . Current alcohol/drug abuse . Pregnant/breast feeding woman .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>schizoaffective disorder</keyword>
	<keyword>quetiapine</keyword>
	<keyword>seroquel</keyword>
	<keyword>titration</keyword>
</DOC>